319: BioMarin's executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion's AI bona fides
It's a guest-free episode this week, giving Allison, Adam and Elaine ample time to chat about the management shakeup at BioMarin, including the announcement that James Sabry, the former Roche dealmake...
22 Aug 202434min
318: Drug pricing drops & psychedelics under fire
STAT’s chief Washington correspondent Rachel Cohrs Zhang joins us to discuss the discounts and how this first round of negotiations between pharmaceutical companies and Medicare officials played out. ...
15 Aug 202421min
317: VC struggles, drug pricing negotiations, & Novo's abrupt Wegovy decision
STAT's Washington Correspondent John Wilkerson joins us to discuss the first round of drug pricing negotiations under the Inflation Reduction Act, which will wrap up by September 1. We also cover the ...
8 Aug 202428min
316: The long journey to make malaria vaccines, and Sarepta's ties with patient advocates
Andrew Joseph, STAT's Europe correspondent, joins us to talk about his special report on the 40-year quest to develop the world's first malaria vaccines. We also cover the latest news in the biotech i...
1 Aug 202434min
315: UnitedHealth's doctor empire, an FDA departure, and Viking's obesity moves
What makes UnitedHealth similar to Standard Oil? Is Viking Therapeutics an attractive acquisition target? And is Adam good at math? We discuss all that and more in this week’s episode of “The Readout ...
25 Jul 202432min
314: JD Vance's biotech ties, Cassava resignations, and insulin shortages
Our Washington correspondent Sarah Owermohle joins us to talk about how JD Vance, Donald Trump's newly announced running mate, could influence health policy if Trump wins the election. We also discuss...
18 Jul 202433min
313: Biotech layoffs, founder-focused VC, & a big pharma exit
STAT's West Coast biotech reporter Jonathan Wosen joins "The Readout LOUD" to discuss what’s driving workforce cuts. Plus, entrepreneurs Alexis Borisy and Zach Weinberg call in to discuss their biotec...
11 Jul 202434min
312: Medicare coverage for GLP-1 drugs, AI, and health care at the presidential debate
STAT health tech reporter Brittany Trang guest co-hosts "The Readout LOUD" this week, where we discuss AI for drug development, the latest in the H5N1 bird flu outbreak, a surprise entrant to the GLP-...
27 Jun 202428min
